UBS Group’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-154,177
| Closed | -$479K | – | 11642 |
|
|
2021
Q4 | $479K | Sell |
154,177
-581,874
| -79% | -$1.96M | ﹤0.01% | 5022 |
|
|
2021
Q3 | $2.66M | Sell |
736,051
-220,468
| -23% | -$832K | ﹤0.01% | 3331 |
|
|
2021
Q2 | $3.42M | Sell |
956,519
-40,408
| -4% | -$143K | ﹤0.01% | 3060 |
|
|
2021
Q1 | $3.9M | Buy |
996,927
+10,431
| +1% | +$43.1K | ﹤0.01% | 2873 |
|
|
2020
Q4 | $4.14M | Buy |
986,496
+975,846
| +9,163% | +$3.76M | ﹤0.01% | 2656 |
|
|
2020
Q3 | $40K | Sell |
10,650
-25,164
| -70% | -$107K | ﹤0.01% | 5812 |
|
|
2020
Q2 | $156K | Sell |
35,814
-22,794
| -39% | -$102K | ﹤0.01% | 4986 |
|
|
2020
Q1 | $222K | Sell |
58,608
-62,503
| -52% | -$307K | ﹤0.01% | 4642 |
|
|
2019
Q4 | $765K | Buy |
121,111
+42,910
| +55% | +$252K | ﹤0.01% | 4460 |
|
|
2019
Q3 | $329K | Buy |
78,201
+45,871
| +142% | +$196K | ﹤0.01% | 4881 |
|
|
2019
Q2 | $150K | Sell |
32,330
-24,635
| -43% | -$115K | ﹤0.01% | 5110 |
|
|
2019
Q1 | $302K | Buy |
56,965
+42,915
| +305% | +$196K | ﹤0.01% | 4366 |
|
|
2018
Q4 | $52K | Sell |
14,050
-3,926
| -22% | -$13.8K | ﹤0.01% | 6067 |
|
|
2018
Q3 | $51K | Buy |
17,976
+3,426
| +24% | +$9.62K | ﹤0.01% | 6159 |
|
|
2018
Q2 | $43K | Sell |
14,550
-4,842
| -25% | -$11.5K | ﹤0.01% | 6117 |
|
|
2018
Q1 | $44K | Buy |
19,392
+1,867
| +11% | +$4.37K | ﹤0.01% | 5823 |
|
|
2017
Q4 | $52K | Buy |
17,525
+2,347
| +15% | +$6.49K | ﹤0.01% | 5816 |
|
|
2017
Q3 | $45K | Buy |
15,178
+528
| +4% | +$1.61K | ﹤0.01% | 5871 |
|
|
2017
Q2 | $41K | Sell |
14,650
-1,695
| -10% | -$3.58K | ﹤0.01% | 5809 |
|
|
2017
Q1 | $31K | Sell |
16,345
-1,861
| -10% | -$3.59K | ﹤0.01% | 5850 |
|
|
2016
Q4 | $32K | Buy |
18,206
+9,856
| +118% | +$20.1K | ﹤0.01% | 6199 |
|
|
2016
Q3 | $23K | Sell |
8,350
-10,174
| -55% | -$25.8K | ﹤0.01% | 6209 |
|
|
2016
Q2 | $44K | Buy |
18,524
+9,174
| +98% | +$25.3K | ﹤0.01% | 5624 |
|
|
2016
Q1 | $30K | Sell |
9,350
-3,030
| -24% | -$11.2K | ﹤0.01% | 5909 |
|
|
2015
Q4 | $59K | Buy |
12,380
+2,244
| +22% | +$12.7K | ﹤0.01% | 5687 |
|
|
2015
Q3 | $57K | Sell |
10,136
-3,747
| -27% | -$27.7K | ﹤0.01% | 5729 |
|
|
2015
Q2 | $110K | Sell |
13,883
-4,378
| -24% | -$37.6K | ﹤0.01% | 5322 |
|
|
2015
Q1 | $192K | Sell |
18,261
-2,624
| -13% | -$35.9K | ﹤0.01% | 4929 |
|
|
2014
Q4 | $251K | Buy |
+20,885
| New | +$317K | ﹤0.01% | 4822 |
|
Other funds holding BDSI
UBS Group's BDSI Position: Q1 2022 in Review
UBS Group sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 154,177 shares — an estimated $479K sold.
UBS Group first reported a position in BDSI in Q4 2014 and held it in 29 quarters. The position peaked at $4.14M in Q4 2020. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- UBS Group reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- UBS Group sold 154,177 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $479K.
- UBS Group first reported a position in BioDelivery Sciences International, Inc. in Q4 2014 and held it in 29 quarters.
- UBS Group's BioDelivery Sciences International, Inc. position peaked at $4.14M in Q4 2020.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.